e-ISSN: 2148-0842
Spinal ve Periferik Sinir Cerrahisi Bülteni
TND-SPSCG
Spinal ve Periferik Sinir Cerrahisi Bülteni

Spinal ve Periferik Sinir Cerrahisi Bülteni

2022, Sayı 95, No, 2     (Sayfalar: 28-38)

The Effects of Intradiscal Pharmacomolecular Agent Applications on Intervertebral Disc Regeneration

Hidayet Safak Ci̇ne 1 ,Mehmet Sabri Gürbüz 2

1 Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi, Beyin ve Sinir Cerrahisi Kliniği, İstanbul
2 İstanbul Medeniyet Üniversitesi, Tıp Fakültesi, Beyin ve Sinir Cerrahisi Anabilim Dalı, İstanbul

Görüntüleme: 707
 - 
İndirme : 239

Low back pain is a common symptom characterized by pain in the lower back, tension or stiffness in the muscles and tendons. It can be caused by spinal conditions such as intervertebral disc degeneration (IDD), lumbar disc herniation, spinal stenosis, spinal instability, and spondylosis. The development of IDD is dependent on genetic predisposition, excessive and imbalanced biomechanical loading, impaired tissue nutrition, aging, infection, trauma, and lifestyle factors. Treatment for low back pain can be grouped into medical treatment, physical therapy and rehabilitation, interventional therapies, and surgical treatment. Regenerative therapies are an area of research focused on repairing and regenerating degenerated discs. Intradiscal injection, a minimally invasive treatment protocol performed under guidance from auxiliary guides such as computed tomography, fluoroscopy, ultrasound, is carried out using various drugs. These drugs include biological reactants such as oxygen-ozone mixture, steroids, methylene blue, platelet-rich plasma (PRP), stem cells, and hydrogel. These treatments have the potential to repair and regenerate degenerated discs.

Anahtar Kelimeler : Degeneration, Intradiscal pharmacomolecular agents, Regeneration